Analysts Raise Estimates, Price Target on PerkinElmer | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Several Wall Street analysts have raised their 2012 estimates and price target on PerkinElmer after the firm reported strong fourth-quarter results that beat expectations on the top and bottom line.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.